Speakers
Prof. Nebojsa Lalic
IDF Europe Regional Chair – Opening remarks
Erik Werson
Person living with type 2 diabetes – Testimonial: the personal experience of a person living with T2D, from diagnosis to treatment implementation.
Prof. Kamlesh Khunti
Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester and Leicester General Hospital, UK – T2D and the legacy effect: why is it critical to act early at diagnosis?
Prof. Tadej Battelino
Head of the Department of Pediatric and Adolescent Endocrinology at University Medical Center Ljubljana, Slovenia – Overcoming therapeutic inertia: early therapy intensification with disease-modifying medications to improve health outcomes for people living with type 2 diabetes.
Franc Bogovic MEP
The MEP Interest Group on Diabetes - MEPs Mobilising for Diabetes (MMD) - Reducing the burden of T2D on people and health systems: is there a political will?
Maurizio Guidi
Chair of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Diabetes Platform - Overcoming barriers to the implementation of clinical recommendations: reducing inequalities within and between countries
After their initial statements, our guest speakers will engage in a panel discussion about the current barriers preventing early and tight control of T2D and its associated risk factors, and the role that people living with diabetes, healthcare professionals, policy makers, payors and industry can play to tackle these challenges and avoid the development of long-term complications and premature mortality in T2D.
Moderator
Mariam Zaidi
EURACTIV
Schedule
12:30 – 12:35 Welcome and opening remarks
12:35 – 12:50 Panellist statements
12:50 – 13:40 Discussion and Q&A
13:40 – 13:45 Closing statements
Followed by a light networking lunch.